| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 41,155.0 | 32,649.0 |
| Profit before tax | 216.0 | 134.0 |
| Net income | 162.0 | 195.0 |
| EPS (diluted, $ a share) | $1.33 | $1.62 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | -16.9% |
|---|---|
| Revenue, year on year | +26.1% |
| Operating margin | 0.2% |
10-Q filed with the SEC, NYSE: HUM. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Humana Inc: key numbers
- Share price
- $461.25Close, Nov 16
- Market cap
- $55.4B
- Shares outstanding
- 120.1MLatest SEC cover page
- Sector
- Finance
- Industry
- Hospital & Medical Service PlansSIC 6324
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Humana Inc
All →Humana $1.5B Debt Financing
Humana Inc. announced the pricing and results of its cash tender offers to repurchase up to $1.5 billion in aggregate purchase price of several series of its outstanding senior notes. The offers were part of a debt management strategy to retire various notes maturing between 2027 and 2032 using cash on hand.
- Value
- $1.5B
Humana Insider Wayne A.i. Frederick Sells $194K of Stock
Wayne A.i. Frederick sold 440 shares of Humana Inc at $440.57 a share, worth $194K in total on Nov 10, 2026. Shares held after the trade: 0 (-100.0%).
- Value
- $194K
- Shares
- 440
- Price
- $440.57
- Holding change
- -100.0%
- Trade date
- Nov 10, 2026
Humana CLO Joseph C. Ventura Sells $2.38M of Stock
Joseph C. Ventura, CLO, sold 5,495 shares of Humana Inc at $433.85 a share, worth $2.38M in total on Nov 9, 2026. Shares held after the trade: 21,910 (-20.1%).
- Value
- $2.38M
- Shares
- 5,495
- Price
- $433.85
- Role
- CLO
- Holding change
- -20.1%
- Trade date
- Nov 9, 2026
Humana $1.5B Debt Financing
Humana Inc. has commenced cash tender offers to purchase up to $1.5 billion in aggregate purchase price of eight different series of its outstanding senior notes. The offers include various notes with maturities ranging from 2027 to 2032, subject to acceptance priority levels and a specific $800 million series cap for the 5.375% Senior Notes due 2031. This debt management transaction allows the company to retire existing higher-interest or near-term debt using available liquidity.
- Value
- $1.5B
Humana Financial Results
Humana reported Q3 2026 financial results, including GAAP EPS of $1.33 and an adjusted loss per share of $0.70. The company raised its full-year 2026 adjusted EPS guidance to at least $9.50, up from the previous estimate of at least $9.00, citing favorable benefit ratios in its Insurance segment.
- Term
- Q3 2026
Humana Partnership with BlackRock, Inc. Worth $2.8B
Humana entered into a new strategic joint venture with BlackRock to manage and operate nearly 150 CenterWell Senior Primary Care clinics. BlackRock will acquire the existing equity stake held by Welsh, Carson, Anderson & Stowe (WCAS) for approximately $2.8 billion, providing Humana with a lower cost of capital and enhanced balance sheet efficiency by removing existing put option liabilities.
- Value
- $2.8B
- Counterparty
- BlackRock, Inc.
- Term
- through 2033